PTPN13 and cancer: A mutational analysis of data from a tyrosine phosphatome-wide study of 157 CRC samples showed that PTPN13 is the second most commonly mutated phosphatase in these cancers (n = 15 tumors with a mutation; 9% of the entire sample) [145].